Skip Content
You are currently on the new version of our website. Access the old version .

9 Results Found

  • Article
  • Open Access
4 Citations
2,745 Views
9 Pages

The hepatitis C virus (HCV) is known as a main etiological cause of chronic hepatitis. HCV infection disturbs cholesterol metabolism of the host, which is frequently observed in patients suffering from chronic hepatitis C (CHC). The course of viral i...

  • Article
  • Open Access
5 Citations
2,917 Views
17 Pages

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients

  • Kamil Grubczak,
  • Anna Grzeszczuk,
  • Monika Groth,
  • Anna Hryniewicz,
  • Anna Kretowska-Grunwald,
  • Robert Flisiak and
  • Marcin Moniuszko

25 July 2021

Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, t...

  • Review
  • Open Access
69 Citations
15,793 Views
24 Pages

S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent

  • Rosa M. Pascale,
  • Maria M. Simile,
  • Diego F. Calvisi,
  • Claudio F. Feo and
  • Francesco Feo

25 January 2022

Alterations of methionine cycle in steatohepatitis, cirrhosis, and hepatocellular carcinoma induce MAT1A decrease and MAT2A increase expressions with the consequent decrease of S-adenosyl-L-methionine (SAM). This causes non-alcoholic fatty liver dise...

  • Article
  • Open Access
13 Citations
3,708 Views
14 Pages

Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens

  • Fengping Wu,
  • Yikai Wang,
  • Dandan Cui,
  • Yan Tian,
  • Rui Lu,
  • Chenrui Liu,
  • Mei Li,
  • Yaping Li,
  • Ning Gao and
  • Shuangsuo Dang
  • + 5 authors

2 January 2023

Little is known about the treatment of patients with hepatitis B surface antigen (HBsAg) recurrence after being clinically cured by peginterferon alpha(peg-IFN-α)-based regimens. This study aimed to investigate the efficacy and safety of peg-IF...

  • Article
  • Open Access
3 Citations
1,715 Views
29 Pages

Background/Objectives: The management of ocular tumours is faced with the challenge of developing a suitable treatment strategy with consideration of the anatomical and physiological protective barriers of the eye. Interferon alpha has been employed...

  • Review
  • Open Access
9 Citations
8,267 Views
18 Pages

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs)

  • Lorenza Di Marco,
  • Simona Cannova,
  • Emanuele Ferrigno,
  • Giuseppe Landro,
  • Rosario Nonni,
  • Claudia La Mantia,
  • Fabio Cartabellotta,
  • Vincenza Calvaruso and
  • Vito Di Marco

24 January 2025

The treatment landscape for hepatitis C virus (HCV) infection has transformed over the past few decades, evolving from the limited efficacy of interferon (IFN) monotherapy to the highly successful pan-genotypic direct-acting antivirals (DAAs) used to...

  • Review
  • Open Access
22 Citations
4,220 Views
12 Pages

23 September 2021

Hepatitis D is the smallest virus known to infect humans, the most aggressive, causing the most severe disease. It is considered a satellite or defective virus requiring the hepatitis B surface antigen (HBsAg) for its replication with approximately 1...

  • Review
  • Open Access
35 Citations
11,867 Views
41 Pages

29 March 2010

Hepatitis C virus (HCV) represents a major health burden, with an estimated 180 million chronically infected individuals worldwide. These patients are at increased risk of developing liver cirrhosis and hepatocellular carcinoma. Infection with HCV is...

  • Article
  • Open Access
4 Citations
4,394 Views
8 Pages

Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection

  • Hongbo Chen,
  • Yinan Yao,
  • Yifan Wang,
  • Hua Zhou,
  • Tianxiang Xu,
  • Jing Liu,
  • Guocheng Wang,
  • Yongfeng Zhang,
  • Xiang Chen and
  • Rongbin Yu
  • + 2 authors

Background: HLA-DM gene, which is related to antigen processing and presentation and located in the non-classical class-II region of human leukocyte antigen (HLA) region, may play a crucial role in chronic hepatitis C virus (HCV) infection treatment...